RX Note

JUNE 9, 2023

FDA Pregnancy and Lactation Labelling Final Rule, 2015 In the past, FDA Pregnancy Categories was used in US. Category A - Adequate and well-controlled studies have failed to demonstrate a risk to the foetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters). B1, B2 and B3 categories).

Adverse Reactions 52

Adverse Reactions Labelling 52

ALiEM - Pharm Pearls

FEBRUARY 28, 2024

Emergency Medicine: Reviews and Perspectives. Photographs, ECGs, Radiology Images These fall into the category of “other multimedia” in the AMA Manual of Style, and here is my best attempt to interpret this to clinical media. Academic Life in Emergency Medicine blog. Cardiology Corner: Hyperkalemia Myths. February 2024.

130

130

STAT

FEBRUARY 29, 2024

And as always, do keep in touch … Amid a slumping stock price and Wall Street doubts, Pfizer chief executive officer Albert Bourla maintains that investors are missing the potential benefits from the recent $43 billion purchase of Seagen, which makes a hot category of cancer treatments called antibody-drug conjugates , STAT explains.

174

174

STAT

JANUARY 23, 2024

The medicine is designed to reduce inflammation and stave off further damage to the tissue. The FDA said it considered the risks of T-cell malignancy, which refers to a group of blood disorders including lymphoma and leukemia, resulting in hospitalization and death, to be applicable to all therapies in the category. Since

Hospitals 194

Hospitals 194

European Pharmaceutical Review

OCTOBER 25, 2023

These recognise outstanding achievements and contributions from the global pharmaceutical industry and supply chain across 12 broad categories. Snapdragon Chemistry, a Cambrex company, was selected as winner of the API Development category. In the Finished Formulation category, Lubrizol Life Science Health was selected as the winner.

Packaging 90

Packaging 90

European Pharmaceutical Review

FEBRUARY 2, 2023

Three categories were available for entry in the Exhibitor Innovations section. The product awarded in the patient-centric design category provides accurate and reliable drug delivery of therapeutic and prophylactic medicinal substances, by intradermal injection.

Packaging 79

Packaging Medication Delivery Biosimilars 79

European Pharmaceutical Review

OCTOBER 27, 2023

According to The Biosimilar Medicines Group, part of Medicines for Europe, a new report by IQVIA indicates there is a window of opportunity for the EU to foster future-proof biosimilar competition. This publication has come in wake of the EU actively reviewing its Pharmaceutical Legislation.

Biosimilars 92

Biosimilars 92

Express Pharma

NOVEMBER 1, 2023

Venus has won the FICCI Healthcare Award 2023 in the “Excellence in Patient Safety and Care” category. The award recognises Venus’s ‘Organ-on-a-Chip’ research model, showcased at the Venus Medicine Research Centre (VMRC), the organisation’s R&D wing.

Drug Development 93

Drug Development 93

European Pharmaceutical Review

DECEMBER 21, 2022

The US Food and Drug Administration (FDA) created live biotherapeutic products (LBP) as a new category in the 2012 guidelines. 1 The European Directorate for the Quality of Medicines & Healthcare (EDQM) also accepted LBP as a new category of medicinal products for the European market in 2019.

Documentation 100

Documentation 100

Quality Matters

NOVEMBER 27, 2023

FDA and created in partnership with FDA’s Health Informatics team, National Institute of Health's National Center for Advancing Translational Sciences (NCATS), and the European Medicines Agency (EMA) to enable the efficient and accurate exchange of information on what substances are in regulated products. Q: What did the new research find?

Compounding 52

Compounding 52

RX Note

FEBRUARY 14, 2024

Introduction Demand for complementary medicines as part of preventive health and wellness care is rising. However, some pharmacists may lack robust knowledge about this category.

Community Pharmacies 52

Community Pharmacies 52

epicur

JANUARY 18, 2024

Category 2 Preparations’ BUD The BUD of category 2 preparations can range from 1 to 90 days based upon how it was sterilized, storage conditions, and if a sterility test was performed and passed. Certain formulations are undergoing stability data testing requirements to meet the criteria of a category 3 preparation.

Compounding 52

Compounding Compounding Pharmacies Dosage Method Validation 52

RX Note

MAY 24, 2023

Introduction The drug prescribing system in government hospitals and clinics is categorized into different prescriber categories, as outlined in the Ministry of Health Medicines Formulary. Budget Control The prescriber category system also serves to control the expenditure related to drugs procurement.

Hospitals 40

Hospitals 40

RX Note

JUNE 3, 2023

Introduction The Ministry of Health Medicines Formulary (MOHMF), “Formulari Ubat Kementerian Kesihatan Malaysia (FUKKM)", or sometimes known as Blue Book, is a list of medications that we can use in Ministry of Health (MOH) facilities. As an overview, the category of prescribers who can initiate prescriptions as follows.

Adverse Reactions 40

Adverse Reactions Dosage Hospitals Labelling 40

Pharmaceutical Technology

DECEMBER 19, 2022

Business Expansion is one of our largest categories and looks at the core functions of business operations within the sector. The Environmental category aims to highlight companies that are undertaking projects that reduce their impact on the natural environment or contribute to its general health. Business Expansion. Innovation.

52

52

European Pharmaceutical Review

NOVEMBER 15, 2023

[Sandoz] has the only major remaining vertically-integrated production network for penicillins in Europe” Penicillins are the leading category of antibiotics worldwide, Sandoz highlighted. The post Sandoz mobilises critical medicine production in Europe appeared first on European Pharmaceutical Review.

Biosimilars 67

Biosimilars 67

Pharmaceutical Technology

JUNE 12, 2023

The company is a specialised pharmaceutical wholesaler and holds a licence, issued by the country’s ministry of health, to import non-registered pharmaceutical products, orphan drugs and other life-saving medicines. Lotus Pharmaceuticals CEO Petar Vazharov stated: “We are delighted at our new collaboration with Teraju.

97

97

Pharmaceutical Technology

APRIL 10, 2023

Galvus specialises in the dipeptidyl peptidase-4 (DPP4) space, specifically in the oral diabetic medication category. Furthermore, Galvus can be used in combination with other medicinal products such as insulin when unable to offer adequate glycaemic control.

Diabetes 52

Diabetes Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

DECEMBER 22, 2022

Business Expansion is one of our largest categories and looks at the core functions of business operations within the sector. The Environmental category aims to highlight companies that are undertaking projects that reduce their impact on the natural environment or contribute to its general health. Business Expansion. Innovation.

Diabetes 52

Diabetes Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

Board Vitals - Pharmacist

DECEMBER 1, 2023

Board Review Features: Earn up to 100 AMA PRA Category 1 Credits Available in 15 medical specialties Audio lectures available via mobile app, CDs, and MP3s Who is AudioDigest ideal for? ABPM LLSA Credits: Preventive Medicine. What is BoardVitals? ABPN SA MOC credits: Psychiatry , Child Psychiatry , and Neurology. ABR SA-CME: Radiology.

Hospitals 52

Hospitals 52

Quality Matters

AUGUST 22, 2023

Official updates have come from the European Medicines Agency, Health Canada, and the Ministry of Health, Labour and Welfare in Japan. New acceptable intake levels Like the revision from EMA, the new FDA guidance establishes new acceptable intake (AI) limits that vary with potency categories and range from 26.5 ng/day to 1500 ng/day.

Compounding 98

Compounding 98

pharmaphorum

DECEMBER 2, 2021

GlaxoSmithKline has formed a five-year partnership with Oxford University to set up a new institute that will apply machine learning and functional genomics to the discovery of new medicines.

Vaccines 76

Vaccines 76

Express Pharma

AUGUST 30, 2023

While prioritizing affordable healthcare remains pivotal, compromising medicine quality stands as an untenable proposition. A meagre two per cent of medicines undergo quality control checks, illuminating a compelling need for rigorous regulation.

Generic Medicine 102

Generic Medicine Dosage Compounding Pharmaceutical Companies 102

pharmaphorum

APRIL 12, 2022

The UK is poised to become the first country in the world to launch a new payment model for antibiotics that could reverse decades of decline in the category. The proposed contracts, which last for ten years, are still in the draft stages, and are expected to be finalised in the coming weeks.

117

117

RX Note

MARCH 18, 2023

Introduction If you are working at government healthcare facilities at Malaysia, you must have referred Ministry of Health Medicines Formulary (MOHMF) before. It is a quick reference for indication, dosage, availability and prescribing category. NOTE: The latest MOHMF database is 2022-3. Database last updated to MOHMF 2022-3.

Hospitals 52

Hospitals Dosage Labelling 52

Pharma in Brief

OCTOBER 5, 2022

The Patented Medicine Prices Review Board ( PMPRB ) has issued a decision that Procysbi (cysteamine bitartrate) is being sold at an “excessive” price. Following amendments to the Patented Medicines Regulations in July 2022, these Guidelines are no longer in force. The Board rejected the proposed new category.

52

52

pharmaphorum

NOVEMBER 11, 2021

In part one of a two-piece series, Leela Barham looks at whether we are getting better at measuring international uptake of medicines. The work concentrates on the five highest health gain (HHG) categories of medicines, comparing England to ten other countries, and it’s connected to the VPAS commitment to measure international uptake.

Dosage 52

Dosage 52

Pharmaceutical Business Review

MARCH 27, 2024

Sanofi India managing director Rodolfo Hrosz said: “Sanofi India’s CNS products are leaders in their respective categories. These well-established brands already improve lives of many patients across urban centres in the country.

Diabetes 59

Diabetes Vaccines 59

pharmaphorum

AUGUST 11, 2022

In the newest episode of the pharmaphorum podcast, editor-in-chief Jonah Comstock welcomes Rebecca Guntern, vice president of medicines for Europe at Sandoz. Tune in to learn more about the world of off-patent medicines: an important category of medications that isn’t going away.

Biosimilars 52

Biosimilars 52

Pharma in Brief

SEPTEMBER 28, 2023

The Patented Medicine Prices Review Board ( PMPRB ) has amended its Interim Guidance to address prices of “New Medicines”, implementing a review threshold based on “below the median” of the PMPRB11 countries (Median International Price, MIP ).

Drug Pricing 52

Drug Pricing 52

Quality Matters

JUNE 26, 2023

The development of generic versions of innovator medicines is a global public health need. Quality standards in particular help ensure medicines are safe, work as intended, and are available when needed, no matter the company producing them or where they are made. Complex generics: Are global regulators addressing the needs?

Dosage 52

Dosage Generic Medicine Labelling 52

Quality Matters

MARCH 8, 2024

Since 1994, dietary supplements have been regulated as a category of foods, meaning that they do not require FDA approval before they are sold to the public. 6 While this test evaluated just one category of supplements, the results are concerning. 7 There are almost 5 billion views of videos discussing supplements on TikTok alone.

Labelling 98

Labelling 98

Pharma in Brief

JUNE 21, 2020

On June 19, 2020, the Patented Medicine Prices Review Board ( PMPRB ) launched its consultation on revised Draft Guidelines to implement the amended Patented Medicines Regulations. Amendments to the Patented Medicines Regulations are scheduled to come into force on January 1, 2021. New patented medicines. Background.

Biosimilars 40

Biosimilars Generic Medicine Dosage Documentation 40

Board Vitals - Pharmacist

JANUARY 4, 2024

Are you ready for your Hospital Medicine MOC Board Exam? After you’re done, see how many of our Hospital Medicine board review questions you answered correctly and brush up on those that you might have gotten wrong. The ABIM Hospital Medicine MOC board exam consists of four sections, each with a maximum of 60 multiple choice questions.

Hospitals 52

Hospitals Inpatient 52

pharmaphorum

NOVEMBER 16, 2022

The 2022 edition of the Access to Medicine Index (ATMI) – which places the top 20 pharma companies for their efforts to improve delivery of medicines to lower income countries – sees GSK retain the number one position, newly joined by Johnson & Johnson in second and AstraZeneca in third. Jayasree Iyer.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies Vaccines 105

Board Vitals - Pharmacist

JANUARY 31, 2023

In addition to the players on the field, there are teams of NFL team doctors and sports medicine specialists who keep the offenses, defenses, and special teams in top shape. Sports Medicine Board Certification is jointly developed by four boards of medicine. The standard for passing is identical for all Boards.

Medical Schools 98

Medical Schools Communication Hospitals 98

pharmaphorum

MAY 11, 2022

The partnership with Flagship will bring Novo Nordisk into closer contact with the VC’s portfolio of 41 biotech companies, with the aim of creating a portfolio of “transformational” medicines for cardiometabolic and rare diseases. The move follows Novo Nordisk’s $3.3

Vaccines 122

Vaccines 122